Pacer Advisors
MGNX icon

Pacer Advisors’s MacroGenics MGNX Stock Holding History

Pacer Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,639
Closed -$24.1K – 3773
2024
Q1 		$24.1K Buy
+1,639
New +$24.8K ﹤0.01% 3408
2021
Q2 		– Sell
-2,627
Closed -$84K – 1492
2021
Q1 		$84K Sell
2,627
-558
-18% -$13.6K ﹤0.01% 1312
2020
Q4 		$73K Buy
3,185
+2,072
+186% +$47.7K ﹤0.01% 1387
2020
Q3 		$28K Buy
+1,113
New +$30.4K ﹤0.01% 1342
2018
Q4 		– Sell
-2,958
Closed -$63K – 846
2018
Q3 		$63K Buy
+2,958
New +$63.1K ﹤0.01% 1129
2018
Q1 		– Sell
-550
Closed -$10K – 1093
2017
Q4 		$10K Buy
+550
New +$10.3K ﹤0.01% 1144

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's MGNX Position: Q2 2024 in Review

Pacer Advisors sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 1,639 shares — an estimated $24.1K sold.

Pacer Advisors first reported a position in MGNX in Q4 2017 and held it in 6 quarters. The position peaked at $84K in Q1 2021. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Pacer Advisors reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,639 MacroGenics shares in Q2 2024, an estimated $24.1K.
  • Pacer Advisors first reported a position in MacroGenics in Q4 2017 and held it in 6 quarters.
  • Pacer Advisors's MacroGenics position peaked at $84K in Q1 2021.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.